N02.B5
Recurrent and persistent immunoglobulin A nephropathy with diffuse mesangial proliferative glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Recurrent and persistent immunoglobulin A (IgA) nephropathy with diffuse mesangial proliferative glomerulonephritis is a chronic kidney condition characterized by the buildup of IgA antibodies in the kidneys, leading to inflammation and damage of the glomeruli. This condition is part of a group of kidney diseases known as glomerulonephritis, specifically involving the mesangial cells in the glomeruli. Over time, it can impair kidney function and potentially progress to kidney failure if not properly managed. Understanding this condition helps in recognizing its features, causes, symptoms, and possible approaches to diagnosis and treatment.
Causes & Symptoms
Clinical Causes: Genetic predisposition: Family history of kidney disease can increase risk. Immune system dysfunction: Abnormal immune responses lead to IgA deposits. Environmental factors: Certain infections or possibly exposure to specific environmental agents. Other health conditions: Linked with liver diseases, celiac disease, or other autoimmune disorders. Recurrent episodes: Previous kidney damage can predispose to ongoing inflammation.
Key Symptoms: Hematuria: Presence of blood in the urine, causing it to appear pink or cola-colored. Proteinuria: Excess protein in the urine, often detected through testing. Swelling: Edema in the hands, feet, abdomen, or around the eyes due to fluid retention. High blood pressure: Elevated blood pressure readings as the kidneys struggle to function. Fatigue: Feeling unusually tired, which may be related to kidney impairment. Frequency of urination: Increased or sometimes decreased urination patterns.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests, including: - Urinalysis: To check for blood and protein in the urine. - Blood tests: To assess kidney function through creatinine and blood urea nitrogen levels. - Imaging studies: Ultrasound to evaluate kidney size and structure. - Kidney biopsy: The definitive test, where a small tissue sample is examined microscopically to confirm IgA deposits and mesangial proliferation. These diagnostic steps help differentiate this condition from other kidney diseases and evaluate the extent of kidney involvement.
Treatment Protocols: Managing recurrent IgA nephropathy with diffuse mesangial proliferative glomerulonephritis aims to slow disease progression and alleviate symptoms: - Medications: - Blood pressure control with ACE inhibitors or ARBs to reduce proteinuria. - Corticosteroids or immunosuppressants in some cases to decrease inflammation. - Diuretics to manage swelling. - Dietary modifications: - Reduced salt intake to lessen fluid retention. - Controlled protein intake to prevent undue kidney stress. - Regular monitoring: - Routine urine and blood tests to track disease activity. - Imaging and periodic biopsies if needed. - Managing underlying conditions: - Treating associated diseases like liver conditions or autoimmune disorders. While some patients may experience stable kidney function over time, others might see progressive decline, emphasizing the importance of tailored management plans.
Clinical Advice & FAQs
Billing Guidance
Is N02.B5 a billable ICD-10 code?
Yes, N02.B5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N02.B5?
Clinical documentation must specify the nature of Recurrent and persistent immunoglobulin A nephropathy with diffuse mesangial proliferative glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference